Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-08 AccNo: 0001104659-18-031096 Size: 4 MB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2018-04-27 AccNo: 9999999995-18-000958 Size: 1 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2018-04-27 AccNo: 9999999995-18-000958 Size: 1 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ CT ORDER - Confidential treatment order Filed: 2018-04-25 AccNo: 9999999997-18-005253 Size: 16 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-04-20 AccNo: 0001104659-18-025618 Size: 20 KBItem 8.01: Other Events 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-04-10 AccNo: 0000902219-18-000432 Size: 37 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2018-04-09 AccNo: 0001104659-18-023059 Size: 643 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-03-27 AccNo: 0001104659-18-020280 Size: 69 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and ...
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-03-16 AccNo: 0001104659-18-018350 Size: 369 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-03-16 AccNo: 0001104659-18-018344 Size: 1 MB 网页链接